Christina Chen

Christina Chen

Auto-generated profile, based on publicly available information

Christina Chen

Clinical Affairs Dexcom, Inc. San Diego California USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Radiology
Verified
Journal Article
Closed access
SKSahar Kazemzadeh
Sahar Kazemzadeh
JYJin Yu
Jin Yu
SJShahar Jamshy
Shahar Jamshy
RPRory Pilgrim
Rory Pilgrim
ZNZaid Nabulsi
Zaid Nabulsi
SPShruthi Prabhakara
Shruthi Prabhakara
A deep learning system trained to detect active pulmonary tuberculosis using de-identified data from 10 countries had a clinical performance comparable to that of nine radiologists on test data sets. Background The World Health Organization (WHO) recommends chest radiography to facilitate tuberculosis (TB) screening. However, chest radiograph interpretation expertise remains limited in many reg...

1 November 2022 in Radiology
Verified
Journal Article
Closed access
ASAndrew B. Sellergren
Andrew B. Sellergren
CCChristina Chen
Christina Chen
ZNZaid Nabulsi
Zaid Nabulsi
YLYuanzhen Li
Yuanzhen Li
AMAaron Maschinot
Aaron Maschinot
SSShravya Shetty
Shravya Shetty
This method enabled prediction performance comparable to state-of-the-art deep learning models in multiple clinical tasks by using as few as 45 chest radiographs. Background Developing deep learning models for radiology requires large data sets and substantial computational resources. Data set size limitations can be further exacerbated by distribution shift...

4 June 2024 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
WWWei-Hung Weng
Wei-Hung Weng
SBSebastien Baur
Sebastien Baur
MDMayank Daswani
Mayank Daswani
CCChristina Chen
Christina Chen
LHLauren Harrell
Lauren Harrell
DADiego Ardila
Diego Ardila
Cardiovascular diseases (CVDs) are responsible for a large proportion of premature deaths in low- and middle-income countries. Early CVD detection and intervention is critical in these populations, yet many existing CVD risk scores require a physical examination or lab measurements, which can be challenging in such health systems due to limited accessibility. We investigated the potential to use photoplethysmography (PPG), a sensing technology available on most smartphones that can potentially enable large-scale screening at low cost, for CVD risk prediction. We developed a deep learning PPG-based CVD risk score (DLS) to predict the probability of having major adverse cardiovascular events (MACE: non-fatal myocardial infarction, stroke, and cardiovascular death) within ten years, given only age, sex, smoking status and PPG as predictors. We compare the DLS with the office-based refit-WHO score, which adopts the shared predictors from WHO and Globorisk scores (age, sex, smoking status, height, weight and systolic blood pressure) but refitted on the UK Biobank (UKB) cohort. All models were trained on a development dataset (141,509 participants) and evaluated on a geographically separate test (54,856 participants) dataset, both from UKB. DLS’s C-statistic (71.1%, 95% CI 69.9–72.4) is non-inferior to office-based refit-WHO score (70.9%, 95% CI 69.7–72.2; non-inferiority margin of 2.5%, p<0.01) in the test dataset. The calibration of the DLS is satisfactory, with a 1.8% mean absolute calibration error. Adding DLS features to the office-based score increases the C-statistic by 1.0% (95% CI 0.6–1.4). DLS predicts ten-year MACE risk comparable with the office-based refit-WHO score. Interpretability analyses suggest that the DLS-extracted features are related to PPG waveform morphology and are independent of heart rate. Our study provides a proof-of-concept and suggests the potential of a PPG-based approach strategies for community-based primary prevention in resource-limited regions.

9 April 2023 in Chest
Verified
Journal Article
Closed access
ACAlyssa Yang Chen
Alyssa Yang Chen
CDChih-Ying Deng
Chih-Ying Deng
PCPaola Calvachi-Prieto
Paola Calvachi-Prieto
MHMiguel Ángel Armengol de la Hoz
Miguel Ángel Armengol de la Hoz
AKAfeefah Khazi-Syed
Afeefah Khazi-Syed
ADAlon Dagan
Alon Dagan

26 September 2024 in NEJM AI
Verified
Journal Article
Open access
SKSahar Kazemzadeh
Sahar Kazemzadeh
AKAtilla P. Kiraly
Atilla P. Kiraly
ZNZaid Nabulsi
Zaid Nabulsi
NSNsala Sanjase
Nsala Sanjase
MMMinyoi Maimbolwa
Minyoi Maimbolwa
SPShruthi Prabhakara
Shruthi Prabhakara
Using artificial intelligence (AI) to interpret chest X-rays (CXRs) could support accessible triage tests for active pulmonary tuberculosis (TB) in resource-constrained settings. The performance of two cloud-based CXR AI systems — one to detect TB and the other to detect CXR abnormalities — in a population with a high TB and human immunodeficiency virus (HIV) burden was evaluated. We recruited 1978 adults who had TB symptoms, were close contacts of known TB patients, or were newly diagnosed with HIV at three clinical sites. The TB-detecting AI (TB AI) scores were converted to binary using two thresholds: a high-sensitivity threshold and an exploratory threshold designed to resemble radiologist performance. Ten radiologists reviewed images for signs of TB, blinded to the reference standard. Primary analysis measured AI detection noninferiority to radiologist performance. Secondary analysis evaluated AI detection as compared with the World Health Organization (WHO) targets (90% sensitivity, 70% specificity). Both used an absolute margin of 5%. The abnormality-detecting AI (abnormality AI) was evaluated for noninferiority to a high-sensitivity target suitable for triaging (90% sensitivity, 50% specificity). Of the 1910 patients analyzed, 1827 (96%) had conclusive TB status, of which 649 (36%) were HIV positive and 192 (11%) were TB positive. The TB AI’s sensitivity and specificity were 87% and 70%, respectively, at the high-sensitivity threshold and 78% and 82%, respectively, at the balanced threshold. Radiologists’ mean sensitivity was 76% and mean specificity was 82%. At the high-sensitivity threshold, the TB AI was noninferior to average radiologist sensitivity (P<0.001) but not to average radiologist specificity (P=0.99) and was higher than the WHO target for specificity but not sensitivity. At the balanced threshold, the TB AI was comparable to radiologists. The abnormality AI’s sensitivity and specificity were 97% and 79%, respectively, with both meeting the prespecified targets. The CXR TB AI was noninferior to radiologists for active pulmonary TB triaging in a population with a high TB and HIV burden. Neither the TB AI nor the radiologists met WHO recommendations for sensitivity in the study population. AI can also be used to detect other CXR abnormalities in the same population.

14 September 2026 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MSMike Schaekermann
Mike Schaekermann
APAnil Palepu
Anil Palepu
ARAdam Rodman
Adam Rodman
APAmi Parekh
Ami Parekh
EGEthan Goh
Ethan Goh
PCPo-Hsuan Cameron Chen
Po-Hsuan Cameron Chen